SanSal Wellness Set for Launch of Veritas Farms Brand of Premium Full Spectrum Hemp Oil and Extract Products
Fort Lauderdale, FL, June 28, 2018 (GLOBE NEWSWIRE) -- SanSal Wellness Holdings, Inc. (“SanSal Wellness” or the “Company”) (OTC PINK: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, is pleased to announce that the Company will launch its new Veritas Farms product line of hemp oil and extract products on July 2, 2018.
The new Veritas Farms product line includes vegan capsules, tinctures, lotions, salves, and oral syringes in a variety of size formats and flavors. The new brand will be immediately available following the July 2 launch through the Company’s new e-commerce website at www.theveritasfarms.com. Investors, shareholders, and potential customers are invited to visit the website pre-launch to register for an early access pricing discount of 20% off their first order. Veritas Farms branded products will also be available through select retailers and healthcare providers commencing in early July.
“We are very excited to have completed development of our Veritas Farms branded lineup of premium hemp oil and extract products and our first e-commerce website,” commented Derek Thomas, Vice President of Business Development of SanSal Wellness. “The introduction of the Veritas Farms premium brand identity will combine SanSal’s superior quality full spectrum whole-plant formulations with a fresh designed modern look that should appeal to a wide audience of consumers and healthcare professionals. The completion of this exhaustive development phase and product launch will enable us to accelerate our planned multi-pronged marketing strategy to reach more potential buyers and tap into new distribution channels across the country.”
Recent industry reports indicate that the market of phytocannabinoid products continues to accelerate and is estimated to grow by 700% by 2020, and a report by market intelligence firm Hemp Business Journal projects that the market will expand to $2.1 billion by 2020, a substantial increase compared to 2017’s market value estimated at $291 million.
Derek Thomas concluded, “SanSal Wellness and its Veritas Farms brands were created with one goal in mind: to offer superior phytocannabinoid products to help people live healthier and happier lives. We accomplish this every day by growing our specially selected strains of phytocannabinoid-rich hemp plants using sustainable farming methods that utilize high-altitude virgin land and pure Rocky Mountain water. This focused attention to detail, along with our strict processing protocols, ensure that everything produced at our farm and facility is of the absolutely highest quality and purity. These will continue to be defining characteristics of our company and our products as we continue to ramp up sales and build a loyal following of satisfied customers that want only the best for themselves and their loved ones.”
SanSal Wellness Holdings, Inc. - IR/Media Contact
Toll-Free: (888) 549-7888
E-mail: investors@sansalwellness.com
About SanSal Wellness Holdings, Inc.
SanSal Wellness Holdings, Inc. (OTC Pink: SSWH) is focused on producing superior quality, whole-plant, broad spectrum phytocannabinoid-rich hemp oils and extracts. SanSal Wellness currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.
For additional information, visit www.sansalwellness.com
Cautionary Language Concerning Forward-Looking Statements
This SanSal Wellness Holdings, Inc. press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Moderna (Nasdaq: MRNA) Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)
